semaglutide gastric intestinal obstruction law office in kentucky lawyer louisiana semaglutide gi firm in louisiana semaglutide gastrointestinal kentucky semaglutide ileus law firm – semaglutide gastric intestinal obstruction law

Switch to smaller, more frequent meals during week two, well before peak symptoms typically appear

According to the MHRA/EMC SmPC, Wegovy commonly causes gastrointestinal side effects including nausea, vomiting, and diarrhoea, particularly during dose escalation

It is a GLP-1 receptor agonist that helps: Control blood sugar levels (reduces HbA1c) Support weight loss (up to 8 kg in diabetic patients) Reduce hunger and appetite Protect heart and kidney health Lower risk of cardiovascular events Ozempic is approved by Indias drug regulator CDSCO in September 2025 and officially launched by Novo Nordisk in December 2025

Glucagon increases blood sugar levels

it symbolizes a new opportunity for many seeking more effective solutions in their weight loss journey or diabetes management